Richard T. Kenney
Chief Medical Officer · Sonnet BioTherapeutics Holdings, Inc.
Individual
- 2024
- Dec 4, 2025
- 4
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Richard T. Kenney's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard T. Kenney?
Richard T. Kenney is a corporate insider, tracked as Chief Medical Officer of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard T. Kenney last file a Form 4?
The most recent primary Form 4 on record is dated 4 December 2025, one of 4 filings going back to 2024.
